KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00750776

Acronym

KvaliMed

Enrollment

212

Registered

2008-09-11

Start date

2003-08-31

Completion date

2012-08-31

Last updated

2013-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antipsychotic Treatment, Medical Treatment, Quality Assurance

Keywords

Quality assurance, medical treatment, Patient satisfaction

Brief summary

Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients where a physician has decided to treat the patient with antipsychotics. * All patients that are treated within the Danish health care system

Exclusion criteria

* Patients that are treated in accordance with Law concerning freedom deprivation and other compulsion in psychiatry * Patients that are in judicial measure

Design outcomes

Primary

Measure	Time frame
GAF score >= 30 or have an improvement on >= 5 points at the GAF scale	All measures are rated every ½ year at least.GAF: At least 85 % of the rated patients must have a score >= 30 or have an improvement on >= 5 points at the GAF scale

Secondary

Measure	Time frame
PANSS: Share af patients that have a score >= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9	PANSS: At least 70% of the patients have a score <= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9
UKU: Share of patients that have a score <=1 on the selected 21 items from the UKU scale	UKU: At least 75 % of the patients have a score on <=1 on the selected items UKU scale.At least 30 % of the patients are examined for metabolic syndrom.
Compliance: Share of patients have according to the specialists evaluation have taken their antipsychotic medicine according to prescription	Compliance: At least 75% of the patients have according to the specialists evaluation taken their antipsychotic medicine according to prescription
Patient satisfaction:Share of patients that scores in one of the to best categories i all selected 3 items in the TSQM scale.	Patient satisfaction:At least 65 % of the patients scores in one of the to best kategories in all the selected 3 items in the TSQM scale.

Countries

Denmark

Outcome results